Analysis of Disease Activity Metrics in a Methotrexate Withdrawal Study among Patients with Rheumatoid Arthritis Treated with Tofacitinib plus Methotrexate

被引：0
|
作者：
Roy Fleischmann
Boulos Haraoui
Maya H. Buch
David Gold
Gosford Sawyerr
Harry Shi
Annette Diehl
Kristen Lee
机构：
[1] Metroplex Clinical Research Center and University of Texas Southwestern Medical Center,Centre for Musculoskeletal Research
[2] Institut de Rhumatologie de Montréal,undefined
[3] University of Manchester,undefined
[4] and NIHR Manchester Biomedical Research Centre,undefined
[5] Pfizer Canada ULC,undefined
[6] Pfizer Inc,undefined
[7] Pfizer Inc,undefined
来源：
Rheumatology and Therapy | 2023年 / 10卷
关键词：
Rheumatoid arthritis; Inflammation; Methotrexate; Therapeutics;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：375 / 386
页数：11
相关论文
共 50 条
  • [1] Analysis of Disease Activity Metrics in a Methotrexate Withdrawal Study among Patients with Rheumatoid Arthritis Treated with Tofacitinib plus Methotrexate
    Fleischmann, Roy
    Haraoui, Boulos
    Buch, Maya H.
    Gold, David
    Sawyerr, Gosford
    Shi, Harry
    Diehl, Annette
    Lee, Kristen
    RHEUMATOLOGY AND THERAPY, 2023, 10 (02) : 375 - 386
  • [2] ANALYSIS OF DISEASE ACTIVITY MEASURES IN THE CONTEXT OF A METHOTREXATE WITHDRAWAL STUDY AMONG PATIENTS WITH RHEUMATOID ARTHRITIS TREATED WITH TOFACITINIB 11 MG ONCE DAILY plus METHOTREXATE: POST HOC ANALYSIS OF DATA FROM ORAL SHIFT
    Fleischmann, R.
    Haraoui, B.
    Buch, M. H.
    Gold, D.
    Sawyerr, G.
    Shi, H.
    Diehl, A.
    Lee, K.
    ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 251 - 251
  • [3] Treating Rheumatoid Arthritis to Target: Outcomes and Predictors in Early Rheumatoid Arthritis Patients Treated with Adalimumab Plus Methotrexate, Methotrexate Alone, or Methotrexate Plus Subsequent Adalimumab
    Smolen, Josef
    Fleischmann, Roy M.
    Emery, Paul
    van Vollenhoven, Ronald F.
    Guerette, Benoit
    Santra, Sourav
    Kupper, Hartmut
    Redden, Laura
    Wolfe, Benjamin
    Kavanaugh, Arthur
    ARTHRITIS AND RHEUMATISM, 2011, 63 (10): : S665 - S665
  • [4] Serious Infections Associated with Tofacitinib in Rheumatoid Arthritis Patients Previously Treated with Methotrexate
    Machado, Marina Amaral de Avila
    Moura, Cristiano S.
    Guerra, Steve Ferreira
    Curtis, Jeffrey R.
    Abrahamowicz, Michal
    Behlouli, Hassan
    Bernatsky, Sasha
    ARTHRITIS & RHEUMATOLOGY, 2017, 69
  • [5] TREATING RHEUMATOID ARTHRITIS TO TARGET: OUTCOMES AND PREDICTORS IN EARLY RHEUMATOID ARTHRITIS PATIENTS TREATED WITH ADALIMUMAB PLUS METHOTREXATE, METHOTREXATE ALONE OR METHOTREXATE PLUS SUBSEQUENT ADALIMUMAB
    Smolen, Josef S.
    Fleischmann, Roy M.
    Emery, Paul
    van Vollenhoven, Ronald F.
    Guerette, Benoit
    Santra, Sourav
    Kupper, Hartmut
    Redden, Laura
    Kavanaugh, Arthur
    RHEUMATOLOGY, 2012, 51 : 114 - 115
  • [6] Impact of Methotrexate Discontinuation, Interruption, or Persistence in US Patients with Rheumatoid Arthritis Initiating Tofacitinib plus Oral Methotrexate Combination
    Cohen, Stanley B.
    Haraoui, Boulos
    Curtis, Jeffrey R.
    Smith, Timothy W.
    Woolcott, John
    Gruben, David
    Murray, Christopher W.
    CLINICAL THERAPEUTICS, 2022, 44 (07) : 982 - +
  • [7] Improvement in hemoglobin in patients with rheumatoid arthritis treated with infliximab plus methotrexate
    Doyle, M. K.
    Rahman, M. U.
    Han, C.
    Han, J.
    Giles, J. T.
    Bingham, C. O., III
    Bathon, J. M.
    ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 : 168 - 168
  • [8] Improvement in hemoglobin in patients with rheumatoid arthritis treated with infliximab plus methotrexate
    Doyle, M.
    Rahman, M.
    Han, C.
    Han, J.
    Giles, J. T.
    Bingham, C. O.
    Bathon, J. M.
    RHEUMATOLOGY, 2008, 47 : II39 - II40
  • [9] Tofacitinib as Monotherapy Following Methotrexate Withdrawal in Patients with Psoriatic Arthritis Previously Treated with Open-label Tofacitinib plus Methotrexate: A Randomized, Placebo-controlled Sub-study of OPAL Balance
    Nash, Peter
    Coates, Laura
    Mease, Philip J.
    Kivitz, Alan
    Gladman, Dafna
    Behrens, Frank
    Wei, James C.
    Fleishaker, Dona
    Wu, Joseph
    Wang, Cunshan
    Romero, Ana
    Fallon, Lara
    Hsu, Ming-Ann
    Kanik, Keith
    ARTHRITIS & RHEUMATOLOGY, 2019, 71
  • [10] Tofacitinib as monotherapy following methotrexate withdrawal in patients with psoriatic arthritis previously treated with open-label tofacitinib plus methotrexate: a randomised, placebo-controlled substudy of OPAL Balance
    Nash, Peter
    Mease, Philip J.
    Fleishaker, Dona
    Wu, Joseph
    Coates, Laura C.
    Behrens, Frank
    Gladman, Dafna D.
    Kivitz, Alan J.
    Wei, James C.
    Shirinsky, Ivan
    Menon, Sujatha
    Romero, Ana B.
    Fallon, Lara
    Hsu, Ming-Ann
    Wang, Cunshan
    Kanik, Keith S.
    LANCET RHEUMATOLOGY, 2021, 3 (01): : E28 - E39
12345